These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibody Production against B19 Virus in Ocular Fluid of JIA-Associated Uveitis Patients. de Groot-Mijnes JD, Dekkers J, de Visser L, Rothova A, van Loon AM, de Boer JH. Ophthalmology; 2015 Jun; 122(6):1270-1272.e1. PubMed ID: 25704320 [No Abstract] [Full Text] [Related]
5. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. Azzi A, Manaresi E, Zakrzewska K, DeSantis R, Musiani M, Zerbini M. J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773 [Abstract] [Full Text] [Related]
6. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis. Zakrzewska K, Azzi A, De Biasi E, Radossi P, De Santis R, Davoli PG, Tagariello G. J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251 [Abstract] [Full Text] [Related]
9. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S. Clin Infect Dis; 2009 Dec 01; 49(11):1660-6. PubMed ID: 19863443 [Abstract] [Full Text] [Related]
10. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence. Lehmann HW, Kühner L, Beckenlehner K, Müller-Godeffroy E, Heide KG, Küster RM, Modrow S. J Clin Virol; 2002 Aug 01; 25(2):135-43. PubMed ID: 12367647 [Abstract] [Full Text] [Related]
11. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women. Hemauer A, Gigler A, Searle K, Beckenlehner K, Raab U, Broliden K, Wolf H, Enders G, Modrow S. J Med Virol; 2000 Jan 01; 60(1):48-55. PubMed ID: 10568763 [Abstract] [Full Text] [Related]
12. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey. Miron D, Luder A, Horovitz Y, Izkovitz A, Shizgreen I, Ben David E, Ohnona FS, Schlesinger Y. Pediatr Infect Dis J; 2006 Oct 01; 25(10):898-901. PubMed ID: 17006284 [Abstract] [Full Text] [Related]
14. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children. Lehmann HW, Lutterbüse N, Plentz A, Akkurt I, Albers N, Hauffa BP, Hiort O, Schoenau E, Modrow S. Viral Immunol; 2008 Sep 01; 21(3):379-83. PubMed ID: 18788945 [Abstract] [Full Text] [Related]
16. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients. Siritantikorn S, Kaewrawang S, Siritanaratkul N, Theamboonlers A, Poovorawan Y, Kantakamalakul W, Wasi C. Asian Pac J Allergy Immunol; 2007 Sep 01; 25(2-3):169-74. PubMed ID: 18035805 [Abstract] [Full Text] [Related]
17. Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients. Obeid OE. J Infect Dev Ctries; 2011 Jul 27; 5(7):535-9. PubMed ID: 21795822 [Abstract] [Full Text] [Related]